ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HEB Hemispherx Biopharma Inc New

1.80
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 33k31k21k56k49k42k46k65k
Operating Income -3.15M-4.7M-6.61M-5.56M-4.3M-5.46M-8.16M-14.03M
Pre Tax Income -3.82M-4.85M-6.39M-4.39M-3.66M-4.91M-7.82M-12.58M
Net Income -3.82M-4.85M-6.39M-4.39M-3.66M-4.91M-7.82M-12.58M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -2.96M-4.7M-5.86M-4.81M-4.06M-5.46M-7.22M-13.27M
EBITDA -3.12M-4.67M-6.58M-5.39M-4.25M-5.38M-8.1M-13.98M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 92k437k367k140k163k135k141k202k
Operating Income -13.8M-11.42M-11.5M-12.44M-15.02M-17.06M-19.92M-31.92M
Pre Tax Income -7.5M-8.26M-9.81M-9.53M-14.4M-19.13M-19.45M-28.96M
Net Income -7.5M-8.26M-9.81M-9.53M-14.4M-19.13M-19.45M-28.96M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.31-0.251-0.201-0.918-0.342-0.399-0.404-0.593
EBIT -9.31M-10.63M-10.52M-10.71M-13.69M-14.52M-18.43M-30.23M
EBITDA -12.64M-10.41M-10.58M-11.65M-14.13M-16.28M-19.67M-31.68M